| Literature DB >> 33170126 |
Erin L Van Blarigan1, Stacey A Kenfield1, Elizabeth Y Wang1,2, Rebecca E Graff1, June M Chan1, Crystal S Langlais1, Jeanette M Broering1, Justin W Ramsdill3, Elizabeth R Kessler4, Kerri M Winters-Stone3.
Abstract
BACKGROUND: Exercise and a healthy diet can improve the quality of life and prognosis of prostate cancer survivors, but there have been limited studies on the feasibility of web-based lifestyle interventions in this population.Entities:
Keywords: cancer survivorship; digital health; internet-based intervention; technology-based intervention; usability
Year: 2020 PMID: 33170126 PMCID: PMC7685923 DOI: 10.2196/19362
Source DB: PubMed Journal: JMIR Cancer ISSN: 2369-1999
Figure 1Screenshots from the Community of Wellness website (different view by level): (a) welcome page (levels 1-4), (b) diet information (levels 1-4), (c) dashboard (level 4), and (d) exercise information (levels 1-4).
Figure 2Community of Wellness study recruitment to intervention and focus groups.
Self-reported characteristics of 20 men with prostate cancer who participated in a 12-week remotely delivered lifestyle intervention and volunteered for a postintervention focus group.
| Characteristics | Level 1 (n=5) | Level 2 (n=4) | Level 3 (n=5) | Level 4 (n=6) | All levels (N=20) | |||
| Age at study enrollment (years), median (IQR) | 71 (71-74) | 73 (69-76) | 68 (68-75) | 63 (56-70) | 70 (66-74) | |||
|
| ||||||||
|
| White | 5 (100) | 3 (75) | 5 (100) | 6 (100) | 19 (95) | ||
|
| Other | 0 (0) | 1 (25) | 0 (0) | 0 (0) | 1 (5) | ||
| Months from intervention end date to focus groups, median (IQR) | 7 (7-8) | 10 (7-14) | 7 (6-12) | 6 (6-12) | 7 (6-12) | |||
| Years from diagnosis to intervention start datea, median (IQR) | 6 (3-8) | 4 (1-24) | 7 (3-8) | 3 (1-4) | 4 (1-8) | |||
| BMI (at diagnosis), median (IQR) | 28 (22-30) | 28 (26-29) | 23.1 (22-27) | 26 (24-32) | 27 (23-29) | |||
|
| ||||||||
|
| T1 | 1 (20) | 1 (25) | 1 (20) | 1 (17) | 4 (20) | ||
|
| T2 | 3 (60) | 1 (25) | 4 (80) | 2 (33) | 10 (50) | ||
|
| T3 or T4 | 1 (20) | 2 (50) | 0 (0) | 2 (33) | 5 (25) | ||
|
| Unknown | 0 (0) | 0 (0) | 0 (0) | 1 (17) | 1 (5) | ||
|
| ||||||||
|
| <7 | 1 (20) | 1 (25) | 1 (20) | 2 (33) | 5 (25) | ||
|
| 7 | 2 (40) | 1 (25) | 2 (40) | 2 (33) | 7 (35) | ||
|
| >7 | 1 (20) | 2 (50) | 2 (40) | 2 (33) | 7 (35) | ||
|
| Unknown | 1 (20) | 0 (0) | 0 (0) | 0 (0) | 1 (5) | ||
|
| ||||||||
|
| At diagnosis | 4.5 (4.0-10.0) | 5.0 (3.7-9.0) | 4.9 (4.0-6.1) | 11.6 (6.0-14.0) | 6.0 (4.0-11.6) | ||
|
| Most recent | 0.4 (0.1-1.0) | 0.0 (0.0-0.2) | 0.1 (0.1-1.0) | 0.1 (0.0-0.2) | 0.1 (0.0-0.7) | ||
|
| ||||||||
|
| Radical prostatectomy | 2 (40) | 3 (75) | 2 (40) | 3 (50) | 10 (50) | ||
|
| Radiation | 2 (40) | 3 (75) | 2 (40) | 4 (67) | 11 (55) | ||
|
|
| 1 (20) | 1 (25) | 0 (0) | 1 (17) | 3 (15) | ||
|
|
|
| 1 (25) | 1 (25) | 0 (0) | 2 (34) | 3 (15) | |
|
|
|
| Abiraterone acetate | 0 (0) | 0 (0) | 0 (0) | 1 (17) | N/Ab |
|
|
|
| Enzalutamide | 1 (25) | 0 (0) | 0 (0) | 0 (0) | N/A |
|
|
|
| Leuprolide acetate | 0 (0) | 1 (25) | 0 (0) | 1 (17) | N/A |
|
|
| Immunotherapy (Sipuleucel-T) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
|
|
| Chemotherapy | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
|
| Active surveillance | 0 (0) | 0 (0) | 1 (20) | 0 (0) | 0 (0) | ||
|
| Other (ie, Radium 223) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | ||
|
| ||||||||
|
| Total number, median (IQR) | 4 (3-7) | 4 (2-6) | 3 (3-3) | 2.5 (1-4) | 3 (2-5) | ||
|
|
| 4 (80) | 3 (75) | 5 (100) | 6 (100) | 18 (90) | ||
|
|
| Heart relatedc | 4 (80) | 1 (25) | 4 (80) | 3 (50) | 12 (60) | |
|
|
| Lung relatedd | 0 (0) | 0 (0) | 0 (0) | 2 (33) | 2 (10) | |
|
|
| Othere | 4 (80) | 3 (75) | 4 (80) | 4 (67) | 15 (75) | |
aYear of diagnosis only reported for 4 men in level 1, 3 men in level 2, 3 men in level 3, and 5 men in level 4.
bN/A: not applicable.
cHeart-related comorbidities include hypertension, angina, congestive heart failure, heart attack, irregularity, stroke, peripheral vascular disease, and deep vein thrombosis.
dLung-related comorbidities include chronic obstructive lung disease, acute respiratory distress syndrome, emphysema, and asthma.
eOther comorbidities include diabetes, neuropathy, hernia, hearing impairment, arthritis, osteoporosis, and back issues.
Figure 3Codes developed using grounded theory analysis: open codes (blue), open codes elevated to axial codes (red), codes elevated to selective codes or categories (orange).
Figure 4Grounded theory-based approaches to increasing prostate cancer survivors’ engagement with web-based Community of Wellness lifestyle intervention: relationships among barriers and motivators related to engagement with web-based behavioral support, with potential solutions (green, ie, Health on the Net).
Participant-inspired recommendations to improve intuitiveness and engagement with remotely delivered behavioral interventions for men with prostate cancer.
| INSERT | Issue | Solution | Recommendations for improvements |
| Environment |
Home environment Competing priorities Other lifestyle programs |
Anticipate and leverage potential sources of friction preventing participation Involve providers Involve family members |
Send letters framed toward stakeholders’ unique role in the patient’s program involvement Leverage existing programs (eg, partner with meal delivery services and/or gyms with discounts for patients with cancer) |
| Motivation |
Accountability Discordance |
Provide longitudinal support Minimize stigma |
Provide quality feedback or monitoring Continue to use judgment-free language |
| Preparedness |
Health literacy Technological literacy Trust Readiness for change |
Assess patient comfort level with technology Assess health literacy Assess readiness to change |
Use tailored web templates based on technological and health literacy Incorporate customizable web interfaces Customize orientation to program Incorporate website navigator Use motivational interviewing techniques to assess baseline readiness and subsequent progression |
| Program design |
Communication (instructions and reminders) Materials Customization (flexibility and tailored feedback) |
Maximize relevant information Minimize extra information |
Construct and use individual profiles per baseline, performance, and other time commitments Add individualized reminder content and frequency Create various versions of the site to match health and technological literacy of the user |
| Program support |
Education Ally Community |
Improve transparency Increase ally availability |
Add Health on the Net certification Emphasize “coach’s” role as expert and support person Allow for updates to profile Add ability to filter resources |